These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16485152)

  • 1. The clinical value of parasternal sentinel node biopsy in breast cancer.
    Leidenius MH; Krogerus LA; Toivonen TS; Leppänen EA; von Smitten KA
    Ann Surg Oncol; 2006 Mar; 13(3):321-6. PubMed ID: 16485152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
    Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
    J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy.
    Leikola J; Heikkilä P; von Smitten K; Leidenius M
    Eur J Surg Oncol; 2006 Jun; 32(5):488-91. PubMed ID: 16569494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
    Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
    Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
    Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
    J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer.
    van der Ent FW; Kengen RA; van der Pol HA; Hoofwijk AG
    Eur J Surg Oncol; 1999 Feb; 25(1):24-9. PubMed ID: 10188850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a standardized protocol for sentinel node imaging in breast cancer with Tc-99m labeled nanocolloidal albumin.
    Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
    Nuklearmedizin; 2001 Jun; 40(3):80-5. PubMed ID: 11475077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node identification in breast cancer patients.
    Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
    Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized sentinel node scintigraphy in breast cancer.
    Paganelli G; De Cicco C; Cremonesi M; Prisco G; Calza P; Luini A; Zucali P; Veronesi U
    Q J Nucl Med; 1998 Mar; 42(1):49-53. PubMed ID: 9646645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A second radioisotope injection enhances intraoperative sentinel node identification in breast cancer patients without visualized nodes on preoperative lymphoscintigraphy.
    Leikola JP; Leppänen EA; von Smitten KA; Leidenius MH
    Acta Radiol; 2006 Oct; 47(8):760-3. PubMed ID: 17050353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer.
    Madsen E; Gobardhan P; Bongers V; Albregts M; Burgmans J; De Hooge P; Van Gorp J; van Dalen T
    Ann Surg Oncol; 2007 Apr; 14(4):1486-92. PubMed ID: 17253106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer.
    Leppänen E; Leidenius M; Krogerus L; von Smitten K
    Eur J Surg Oncol; 2002 Dec; 28(8):821-6. PubMed ID: 12477472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.
    Maza S; Valencia R; Geworski L; Zander A; Guski H; Winzer KJ; Munz DL
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):651-6. PubMed ID: 12612811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
    Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
    Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer.
    Zavagno G; De Salvo GL; Bozza F; Scalco G; Marconato R; Valletta S; Racano C; Burelli P; Nitti D; Lise M
    Breast Cancer Res Treat; 2004 Jul; 86(2):171-9. PubMed ID: 15319569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-Tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging.
    Spanu A; Dettori G; Chessa F; Porcu A; Cottu P; Solinas P; Falchi A; Solinas ME; Scanu AM; Nuvoli S; Madeddu G
    Cancer Biother Radiopharm; 2001 Dec; 16(6):501-13. PubMed ID: 11789027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.